Drugs of Abuse: How Clinical Pharmacology Brings Clarity to the Shadows.

J Clin Pharmacol

BOT Distinguished Professor and Chair, Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, Co-Director, HOPES Research Group, UConn and Hartford Hospital, Hartford, Connecticut, USA.

Published: August 2021

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1921DOI Listing

Publication Analysis

Top Keywords

drugs abuse
4
abuse clinical
4
clinical pharmacology
4
pharmacology brings
4
brings clarity
4
clarity shadows
4
drugs
1
clinical
1
pharmacology
1
brings
1

Similar Publications

[Social Determinants of Combined Use of Alcohol and Non-prescription Drugs in Older Adults: A Population-based Study in Chile].

Rev Med Chil

November 2024

Núcleo de Humanidades y Ciencias Sociales, Universidad del Desarrollo, Santiago, Chile.

Unlabelled: Alcohol consumption by older adults has been called the "silent epidemic." An aging population and high levels of alcohol consumption increase the future challenge for epidemiology and public health. In addition, the misuse of prescription drugs is a growing public health problem associated with increased hospitalizations and health complications in older adults.

View Article and Find Full Text PDF

(PA), as a common pathogen of nosocomial infections, has been experiencing an increasing rate of drug resistance with the widespread use and abuse of antimicrobial drugs. High-drug-resistance and high-virulence phenotypes are two distinctive features of the strong pathogenicity of multi-drug-resistant PA. Exploring the characterization of virulence factor expression and its relationship with the multi-drug resistance phenotype is essential to reduce the further development of resistance as well as a high standard of infection prevention and control.

View Article and Find Full Text PDF

Developing a comprehensive inventory to define harm reduction housing.

Harm Reduct J

January 2025

Opioid Policy Research Collaborative, Heller School for Social Policy & Management, Brandeis University, Waltham, MA, USA.

Background: The City of Boston has faced unprecedented challenges with substance use amidst changes to the illicit drug supply and increased visibility of homelessness. Among its responses, Boston developed six low threshold harm reduction housing (HRH) sites geared towards supporting the housing needs of people who use drugs (PWUD) and addressing health and safety concerns around geographically concentrated tent encampments. HRH sites are transitional supportive housing that adhere to a "housing first" approach where abstinence is not required and harm reduction services and supports are co-located.

View Article and Find Full Text PDF

The opioid crisis, driven by synthetic opioids like fentanyl, demands innovative solutions. The opioid antidote naloxone has a short action ( ~ 1 hour), requiring repeated doses. To address this, we present a new and simple naloxone prodrug delivery system repurposing a hydrophilic derivative of acoramidis, a potent transthyretin ligand.

View Article and Find Full Text PDF

To evade legal controls, new psychoactive substances (NPS), which have been designed as substitutes for traditional and synthetic drugs, are gradually dominating the drug market. Synthetic cannabinoids (SCs), which account for the majority of NPS, are rapidly being derivatized; consequently, controlling increasing abuse by merely listing individual compounds is difficult. Therefore, China has included the entire SC category of SCs listed as legal controlled substances since July 1, 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!